Allen Mooney & Barnes Investment Advisors LLC
Position in ABBV — AbbVie Inc.
CIK 2001461
Thomasville, GA
Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$20,630,957
+$1,481,180 QoQ
Shares Held
81,986
-6.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.56%
of 13F equity value
Holder Rank
#596
of 4,153 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allen Mooney & Barnes Investment Advisors LLC holds $48,976,902 across 7 Drug Manufacturers - General names. ABBV ranks #1 (42.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
81,986 | $20,630,957 | |
| 2 | MRK |
Merck & Co., Inc.
|
126,728 | $16,284,548 | |
| 3 | LLY |
ELI LILLY & Co
|
4,815 | $5,775,255 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
15,709 | $1,984,675 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
33,051 | $1,904,398 | |
| 6 | JNJ |
Johnson & Johnson
|
7,301 | $1,854,234 | |
| 7 | PFE |
Pfizer Inc
|
22,543 | $542,835 |
All Filings in ABBV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,630,957 | 81,986 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $19,149,777 | 88,049 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $19,900,565 | 87,096 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $19,978,428 | 86,285 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $15,869,025 | 85,492 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $17,721,620 | 84,582 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $14,957,186 | 84,171 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $16,707,597 | 84,604 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $14,944,709 | 87,131 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $15,800,270 | 86,767 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $13,629,301 | 87,948 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $12,919,477 | 86,673 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $11,240,658 | 83,431 | Shares | Sole | 2024-05-23 | |
| 2023-03-31 | $13,117,744 | 82,310 | Shares | Sole | 2024-05-23 | |
| 2022-12-31 | $13,143,418 | 81,328 | Shares | Sole | 2024-05-23 | |
| 2022-09-30 | $10,872,754 | 81,013 | Shares | Sole | 2024-05-23 | |
| 2022-06-30 | $12,014,023 | 78,441 | Shares | Sole | 2024-05-23 | |
| 2022-03-31 | $12,580,384 | 77,604 | Shares | Sole | 2024-05-23 | |
| No filing history on record for this holder in this stock. | ||||||